Stock listing
Century Therapeutics, Inc.
Selected listing: IPSC · NASDAQ · USD · US
Century Therapeutics, Inc. (NASDAQ:IPSC), Health Technology. Latest release Oct 2, 2026: Century Therapeutics' CNTY-813 Demonstrates Continued Advancement…
- Ticker
- NASDAQ:IPSC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Century Therapeutics, Inc.
Century Therapeutics, Inc. is a public company traded under the ticker IPSC in the American market. Century Therapeutics focuses on developing innovative cell therapies for cancer treatment.
Latest news from Century Therapeutics, Inc.
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
October 2, 2026
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
October 1, 2026
Century Therapeutics Appoints Joseph Truitt to Board of Directors
September 9, 2026
Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
August 12, 2026
IHI Power Services Corp. Rebrands as Kyuden Energy Partners Following Acquisition by Japan's Kyuden Group
July 23, 2026
Research Century Therapeutics, Inc.
Century Therapeutics, Inc. company profile
View the public company page for Century Therapeutics, Inc. on 6ix.
Century Therapeutics, Inc. news
Read company news and market updates connected to Century Therapeutics, Inc..
Century Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Century Therapeutics, Inc..